29m
Hosted on MSNWe Asked Retail Traders About Eli Lilly’s Biggest Post-Q4 Risk — Most Say It’s The Weight-Loss Drug WarsShares of Eli Lilly finished Thursday 3% higher despite an earnings report that showed sales of its blockbuster GLP-1 ...
US stock futures hit pause on Friday as investors braced for the highly anticipated monthly jobs report and digested Amazon's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results